by 
Cell culture is a technique used to grow and maintain living cells in artificial conditions outside the body. Cell culture offers advantages like ability to control environmental conditions and observe cell behavior which is difficult to study inside a living organism. Cells grown in culture are being used extensively in biomedical research, drug testing and development of therapeutic products.
The global Cell Culture Market is estimated to be valued at US$ 19,198.0 Mn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising demand for cell-based research is one of the key trends propelling the growth of the cell culture market. Cell cultures are extensively used in research related to cancer, stem cells, tissue engineering and regenerative medicine. With increasing incidence of various chronic diseases, cell-based research plays a vital role in developing new treatment and diagnostic methods. According to the National Institutes of Health (NIH), the annual budget for cancer research in the US crossed $6.2 billion in 2020. Such rising investments in cell-based research are fueling the adoption of cell culture techniques and equipment globally. Growth in biopharmaceutical industry and expansion of healthcare infrastructure in emerging nations will further support the market growth over the forecast period.
SWOT Analysis
Strength: Cell culture offers several advantages over animal testing such as consistency, reproducibility and control over culture conditions which facilitates scientific research.
Weakness: High initial setup and maintenance costs associated with cell culture equipment and infrastructure. Risk of contamination also poses challenges.
Opportunity: Increasing R&D investments in life sciences, rising demand for monoclonal antibodies and regenerative medicine offer significant growth opportunities.
Threats: Stringent regulations pertaining to cell culture processes and products pose compliance challenges. Concerns over biosafety of immortalized cell lines used in research also act as a threat.
Key Takeaways
The global cell culture market is expected to witness high growth over the forecast period supported by factors such as increasing research in disease pathology, genomics, immunology, and drug discovery. Increased focus on developing alternative methods to animal testing will also support market expansion. The global Cell Culture Market is estimated to be valued at US$ 19,198.0 Mn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030.
Regional analysis indicates that North America will continue dominating the cell culture market through 2030 owing to presence of major pharmaceutical companies and rising funding for life science research in the US. Asia Pacific is anticipated to exhibit fastest growth led by rising investments in biopharma sector from China, India and other East Asian countries.
Key players operating in the cell culture market are Corning Incorporated, Merck KGaA, Sartorius AG, BioSpherix, Ltd., Cell Culture Company, LLC, Thermo Fisher Scientific Inc., VWR International LLC, and Lonza. These players are focusing on new product launches, expansions and collaborations to consolidate their market position. For instance, in 2022 Thermo Fisher acquired Cytiva to expand its offerings in continuous manufacturing space.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
